In a sepsis-induced AKI mouse model, the administration of UC-MSC-EVs showed a therapeutic effect by modulating inflammation through the inhibition of the NF-kB pathway induced by miR-140b up-regulation [27]. Here, NFKB1 is linked to acute kidney injury.